Progyny Inc (PGNY)
32.38
+0.31
(+0.97%)
USD |
NASDAQ |
May 01, 15:38
Progyny Accounts Receivable (Quarterly): 241.87M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 241.87M |
September 30, 2023 | 268.77M |
June 30, 2023 | 264.96M |
March 31, 2023 | 313.24M |
December 31, 2022 | 240.07M |
September 30, 2022 | 258.04M |
June 30, 2022 | 229.86M |
March 31, 2022 | 198.12M |
December 31, 2021 | 134.56M |
September 30, 2021 | 135.18M |
Date | Value |
---|---|
June 30, 2021 | 140.77M |
March 31, 2021 | 116.67M |
December 31, 2020 | 75.66M |
September 30, 2020 | 78.30M |
June 30, 2020 | 65.00M |
March 31, 2020 | 65.86M |
December 31, 2019 | 47.06M |
September 30, 2019 | 44.34M |
June 30, 2019 | 44.24M |
December 31, 2018 | 23.32M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
44.24M
Minimum
Jun 2019
313.24M
Maximum
Mar 2023
155.92M
Average
135.18M
Median
Sep 2021
Accounts Receivable (Quarterly) Benchmarks
Delcath Systems Inc | 0.241M |
Star Equity Holdings Inc | 6.004M |
Exact Sciences Corp | 203.62M |
Illumina Inc | 734.00M |
CytoSorbents Corp | 6.057M |